Impact of sleep as a specific marker of quality of life in allergic rhinitis

Current Allergy and Asthma Reports

Volumn 13, Issue 2, 2013, Pages 131-141

  González Núñez, Vanesa ^a   Valero, Antonio Luís ^b   Mullol, Joaquim ^b  

^a HOSPITAL QUIRÓN   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Allergic rhinitis; Allergy; Antihistamine; ARIA; Blocked nose; Circadian rhythm; Daytime fatigue; Intermittent; Intranasal corticosteroid; Nasal congestion; Nasal symptoms; Perennial; Persistent; Quality of life; Quality of sleep; Questionnaire; Seasonal; Sleep; Sleep disturbance; Sleep problems; Sleep disordered breathing; Sleepiness; Somnolence; Stuffy nose

Indexed keywords

CORTICOSTEROID; DECONGESTIVE AGENT; HISTAMINE H1 RECEPTOR ANTAGONIST; LEUKOTRIENE RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER;

ADVERSE OUTCOME; ALLERGIC RHINITIS; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ASSESSMENT TOOL; DAILY LIFE ACTIVITY; DAYTIME SOMNOLENCE; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; DRIVING ABILITY; FATIGUE; HIGH RISK PATIENT; HUMAN; NONHUMAN; NOSE OBSTRUCTION; PRODUCTIVITY; QUALITY OF LIFE; QUESTIONNAIRE; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SLEEP QUALITY; SOCIAL INTERACTION; TASK PERFORMANCE; PATHOPHYSIOLOGY; PERENNIAL RHINITIS; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; REVIEW; SLEEP; SLEEP STAGE;

ACTIVITIES OF DAILY LIVING; BIOLOGICAL MARKERS; HUMANS; QUALITY OF LIFE; RHINITIS, ALLERGIC, PERENNIAL; SLEEP; SLEEP DISORDERS; SLEEP STAGES;

MLCS; MLOWN;

EID: 84876341222     PISSN: 15297322     EISSN: 15346315     Source Type: Journal    
DOI: 10.1007/s11882-012-0330-z     Document Type: Article

References (99)

1. Bousquet J, Khaltaev N, Cruz A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008. Allergy. 2008;63 Suppl 86:8-160.
2. Meltzer EO, Blaiss MS, Derebery J, et al. Burden of allergic rhinitis: results from the Pediatric Allergies in America survey. J Allergy Clin Immunol. 2009;124:S43-70.
3. Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J. 2004;24:758-64.
4. Bachert C, van Cauwenberge P, Olbrecht J, et al. Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium. Allergy. 2006;61:693-8.
5. •• Craig TJ, Sherkat A, Safaee S. Congestion and sleep impairment in allergic rhinitis. Curr Allergy Asthma Rep. 2010;10:113-21. This review examines nasal congestion and the associated sleep impairment of allergic rhinitis patients.
6. Meltzer EO, Nathan R, Derebery J, et al. Sleep, quality of life, and productivity impact of nasal symptoms in the United States: findings from the burden of rhinitis in America survey. Allergy Asthma Proc. 2009;30:244-54.
7. Bousquet J, Van Cauwenberge P, Khaltaev N, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) in collaboration with the World Health Organization (WHO). J Allergy Clin Immunol. 2001;108:S147-336.
8. Valero A, Ferrer M, Baró E, et al. Discrimination between moderate and severe disease may be used in patients with either treated or untreated allergic rhinitis. Allergy. 2010;65:1609-13.
9. Valero A, Ferrer M, Sastre J, et al. A new criterion by which to discriminate between patients with moderate allergic rhinitis and patients with severe allergic rhinitis based on the Allergic Rhinitis and its Impact on Asthma severity items. J Allergy Clin Immunol. 2007;120:359-65.
10. Pratt EL, Craig TJ. Assessing outcomes from the sleep disturbance associated with rhinitis. Curr Opin Allergy Clin Immunol. 2007;7:249-56.
11. Shedden A. Impact of nasal congestion on quality of life and work productivity in allergic rhinitis. Treat Respir Med. 2005;4:439-46.
12. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy. 1991;21:77-83.
13. Smolensky M, Reinberg A, Labrecque G. Twenty-four hour pattern in symptom intensity of viral and allergic rhinitis: treatment implications. J Allergy Clin Immunol. 1995;95:1084-96.
14. Santos CB, Pratt EL, Hanks C, et al. Allergic rhinitis and its effect on sleep, fatigue, and daytime somnolence. Ann Allergy Asthma Immunol. 2006;97:579-87.
15. Reinberg A, Gervais P, Levi F, et al. Circadian and circannual rhythms of allergic rhinitis: an epidemiologic study involving chronobiologic methods. J Allergy Clin Immunol. 1988;81:51-62.
16. • Bousquet J, Neukirch F, Bousquet PJ, et al. Severity and impairment of allergic rhinitis in patients consulting in primary care. J Allergy Clin Immunol. 2006;117:158-62. In this study, performed in general practice on a large number of patients with allergic rhinitis, the severity of the rhinitis was having more effect on QOL, sleep, daily activities, and work performance than in the duration.
17. Leynaert B, Neukirch C, Liard R, et al. Quality of life in allergic rhinitis and asthma. Am J Respir Crit Care Med. 2000;162:1391-6.
18. Juniper EF, Thompson AK, Ferrie PJ, et al. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol. 1999;104:364-9.
19. Baiardini I, Braido F, Brandi S, et al. Allergic diseases and their impact on quality of life. Ann Allergy Asthma Immunol. 2006;97:419-29.
20. Juniper EF, Guyatt GH, Andersson B, et al. Comparison of powder and aerosolized budesonide in perennial rhinitis: validation of rhinitis quality of life questionnaire. Ann Allergy. 1993;70:225-30.
21. Juniper EF, Thompson AK, Ferrie PJ, et al. Development and validation of the Mini Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exp Allergy. 2000;30:132-40.
22. Juniper EF, Rohrbaugh T, Meltzer EO. A questionnaire to measure quality of life in adults with nocturnal allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2003;111:484-90.
23. Santilli J, Nathan R, Glassheim J, et al. Validation of the rhinitis outcomes questionnaire (ROQ). Ann Allergy Asthma Immunol. 2001;86:222-5.
24. Baiardini I, Pasquali M, Giardini A, et al. Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma. Allergy. 2003;58:289-94.
25. Juniper EF, Howland WC, Roberts NB, et al. Measuring quality of life in children with rhinoconjunctivitis. J Allergy Clin Immunol. 1998;101:163-70.
26. Flemons WW, Tsai W. Quality of life consequences of sleep-disordered breathing. J Allergy Clin Immunol. 1997;99:S750-6.
27. Bousquet J, Bullinger M, Fayol C, et al. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immnol. 1994;94:182-8.
28. Juniper EF. Measuring health-related quality of life in rhinitis. J Allergy Clin Immunol. 1997;99:S742-9.
29. ESPRINT study group. Development and validation of a new Spanish instrument to measure health-related quality of life in patients with allergic rhinitis: The Esprint Questionnaire. Val Health. 2007;10(6):466-77.
30. Kremer B, den Hartog HM, Jolles J. Relationship between allergic rhinitis, disturbed cognitive functions and psychological well-being. Clin Exp Allergy. 2002;32:1310-5.
31. Blaiss MS. Quality of life in allergic rhinitis. Ann Allergy Asthma Immunol. 1999;83:449-54.
32. Kremer B. Quality of life scales in allergic rhinitis. Curr Opin Allergy Clin Immunol. 2004;4:171-6.
33. Miraglia Del Giudice M, Marseglia A, Leonardi S, et al. Allergic rhinitis and quality of life in children. Int J Immunopathol Pharmacol. 2011;24(S):25-8.
34. van Oene CM, van Reij JF, Sprangers MAG, et al. Quality-assessment of disease-specific quality of life questionnaires for rhinitis and rhinosinusitis: a systematic review. Allergy. 2007;62:1359-71.
35. Stuck BA, Czajkowski J, Hagner A, et al. Changes in daytime sleepiness, quality of life, and objective sleep patterns in seasonal allergic rhinitis: a controlled clinical trial. J Allergy Clin Immunol. 2004;113:663-8.
36. •• Colás C, Galera H, Añibarro B, et al. Disease severity impairs sleep quality in allergic rhinitis (The SOMNIAAR study). Clin Exp Allergy. 2012;42:1080-7. This study shows that sleep quality is altered in AR patients, and that a greater severity of AR is correlated with a poorer sleep quality.
37. Juniper EF, Guyatt GH, Dolovich J. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials. J Allergy Clin Immunol. 1994;93:413-23.
38. Valero A, Alonso J, Antépara I, et al. Health-related quality of life in allergic rhinitis: comparing the short form ESPRINT-15 and MiniRQLQ questionnaires. Allergy. 2007;62(12):1372-8.
39. Valero A, Baró E, Sastre J, et al. Reference values for facilitating the interpretation of the ESPRINT-15 questionnaire (Spanish version). J Investig Allergol Clin Immunol. 2009;19(5):396-403.
40. Vuurman EF, van Veggel LM, Uiterwijk MM, et al. Seasonal allergic rhinitis and antihistamine effects on children's learning. Ann Allergy. 1993;71(2):121-6.
41. Léger D, Annesi-Maesano I, Carat F, et al. Allergic rhinitis and its consequences on quality of sleep. Arch Intern Med. 2006;166:1744-8.
42. Soose RJ. Role of allergy in sleep-disordered breathing. Otolaryngol Clin N Am. 2011;44:625-35.
43. Hoddes E, Zarcone V, Smythe H, et al. Quantification of sleepiness: a new approach. Psychophysiology. 1973;10:431-6.
44. Jenkins CD, Stanton BA, Niemcryk SJ, et al. A scale for the estimation of sleep problems in clinical research. J ClinEpidemiol. 1988;41:313-21.
45. Lallukka T, Dregan A, Armstrong D. Comparison of a sleep item from the General Health Questionnaire-12 with the Jenkins Sleep Questionnaire as measures of sleep disturbance. J Epidemiol. 2011;21:474-80.
46. Buysse DJ, Reynolds CF, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193-213.
47. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep. 1991;14:540-5.
48. Weaver TE, Laizner AM, Evans LK, et al. An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep. 1997;20:835-43.
49. Hays RD, Martin SA, Sesti AM, et al. Psychometric properties of the Medical Outcomes Study Sleep measure. Sleep Med. 2005;6:41-4.
50. Chervin RD, Hedger K, Dillon JE, et al. Pediatric sleep questionnaire (PSQ): validity and reliability of scales for sleep-disordered breathing, snoring, sleepiness, and behavioral problems. Sleep Med. 2000;1:21-31.
51. • Ishman SL, Smith DF, Benke JR, et al. The prevalence of sleepiness and the risk of sleep-disordered breathing in children testing positive for allergy. Int Forum Allergy Rhinol. 2012;2:139-43. This study suggests that children with AR are at increased risk for sleep-disordered breathing.
52. Drake C, Nickel C, Rothe T, et al. The pediatric daytime sleepiness scale (PDSS): sleep habits and school outcome in middle-school children. Sleep. 2003;26:455-8.
53. Baiardini I, Braido F, Cauglia S, et al. Sleep disturbances in allergic diseases. Allergy. 2006;61:1259-67.
54. • Sardana N, Craig TJ. Congestion and sleep impairment in allergic rhinitis. Asian Pac J Allergy Immunol. 2011;29:297-306. This review examines nasal congestion and the associated sleep impairment in allergic rhinitis.
55. Gurevich F, Glass C, Davies M, et al. The effect of intranasal steroid budesonide on the congestion-related sleep disturbance and daytime somnolence in patients with perennial allergic rhinitis. Allergy Asthma Proc. 2005;26:268-74.
56. Lavie P, Gertner R, Zomer J, et al. Breathing disorders in sleep associated with "microarousals" in patients with allergic rhinitis. Acta Otolaryngol. 1981;92:529-33.
57. Young T, Finn L, Kim H. Nasal obstruction as a risk factor for sleep-disordered breathing. J Allergy Clin Immunol. 1997;99:S757-62.
58. Craig TJ, Teets S, Lehman E, et al. Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids. J Allergy Clin Immunol. 1998;101:633-7.
59. Young T, Finn L, Palta M. Chronic nasal congestion at night is a risk factor for snoring in a population-based cohort study. Arch Intern Med. 2001;161:1514-9.
60. Krouse HJ, Davis JE, Krouse JH. Immune mediators in allergic rhinitis and sleep. Otolaryngol Head Neck Surg. 2002;126:607-13.
61. Craig TJ, Mende C, Hughes K, et al. The effect of topical nasal fluticasone on objective sleep testing and the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis. Allergy Asthma Proc. 2003;24:53-8.
62. Hughes K, Glass C, Ripchinski M, et al. Efficacy of the topical nasal steroid budesonide on improving sleep and daytime somnolence in patients with perennial allergic rhinitis. Allergy. 2003;58:380-5.
63. Benninger MS, Benninger RM. The impact of allergic rhinitis on sexual activity, sleep, and fatigue. Allergy Asthma Proc. 2009;30:358-65.
64. Stull DE, Schaefer M, Crespi S, et al. Relative strength of relationships of nasal congestion and ocular symptoms with sleep, mood and productivity. Curr Med Res Opin. 2009;25:1785-92.
65. Yuksel H, Sogut A, Yilmaz H, et al. Sleep actigraphy evidence of improved sleep after treatment of allergic rhinitis. Ann Allergy Asthma Immunol. 2009;103:290-4.
66. Meltzer EO, Munafo DA, Chung W, et al. Intranasal mometasone furoate therapy for allergic rhinitis symptoms and rhinitis-disturbed sleep. Ann Allergy Asthma Immunol. 2010;105:65-74.
67. Meng J, Xuan J, Qiao X, et al. Assessment of sleep impairment in persistent allergic rhinitis patients using polysomnography. Int Arch Allergy Immunol. 2011;155:57-62.
68. Sherkat AA, Sardana N, Safaee S, et al. The role of pseudoephedrine on daytime somnolence in patients suffering from perennial allergic rhinitis (PAR). Ann Allergy Asthma Immunol. 2011;106:97-102.
69. Yamada T, Yamamoto H, Kubo S, et al. Efficacy of mometasone furoate nasal spray for nasal symptoms, quality of life, rhinitis-disturbed sleep, and nasal nitric oxide in patients with perennial allergic rhinitis. Allergy Asthma Proc. 2012;33:e9-e16.
70. Chivato T, Valovirta E, Dahl R, et al. Allergy, living and learning: diagnosis and treatment of allergic respiratory diseases in Europe. J Investig Allergol Clin Immunol. 2012;22:168-79.
71. Blaiss M, Reigel T, Philpot E. A study to determine the impact of rhinitis on sufferers' sleep and daily routine [abstract 787]. J Allergy Clin Immunol. 2005;115:S197.
72. Kakumanu S, Glass C, Craig T. Poor sleep and daytime somnolence in allergic rhinitis: significance of nasal congestion. Am J Respir Med. 2002;1(3):195-200.
73. McNicholas WT, Tarlo S, Cole P, et al. Obstructive sleep apneas during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis. 1982;126:625-8.
74. Rappai M, Collop N, Kemp S, et al. The nose and sleep-disordered breathing. What we do not know. Chest. 2003;124:2309-23.
75. Modrzynski M, Zawisza E. An analysis of the incidence of adenoid hypertrophy in allergic children. Int J Pediatr Otorhinolaryngol. 2007;71:713-9.
76. Craig TJ, Ferguson BJ, Krouse JH. Sleep impairment in allergic rhinitis, rhinosinusitis, and nasal polyposis. Am J Otolaryngol. 2008;29:209-17.
77. Zwillich CW, Picket C, Hanson FN, et al. Disturbed sleep and prolonged apnea during nasal obstruction in normal men. Am Rev Respir Dis. 1981;124(2):158-60.
78. Anuntaseree W, Rookkapan K, Kuasirikul S, et al. Snoring and obstructive sleep apnea in Thai scool-age children: prevalence and predisposing factors. Pediatr Pulmonol. 2001;32:222-7.
79. Chng SY, Goh DY, Wang XS, et al. Snoring and atopic disease: a strong association. Pediatr Pulmonol. 2004;38:210-6.
80. Kalra M, Lemasters G, Bernstein D, et al. Atopy as a risk factor for habitual snoring at age 1 year. Chest. 2006;129:942-6.
81. McCollley SA, Carroll JL, Curtis S, et al. High prevalence of allergic sensitization in children with habitual snoring and obstructive sleep apnea. Chest. 1997;111:170-3.
82. Mullol J, Maurer M, Bousquet J. Sleep and allergic rhinitis. J Investig Allergol Clin Immunol. 2008;18:415-9.
83. Craig TJ, Hanks CD, Fisher LH. How do topical nasal corticosteroids improve sleep and daytime somnolence in allergic rhinitis? J Allergy Clin Immunol. 2005;116:1264-6.
84. Weiner JM, Abramson MJ, Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review or randomized controlled trials. BMJ. 1998;317:1624-9.
85. Bender BG, Milgrom H. Comparison of the effects of fluticasone propionate aqueous nasal spray and loratadine on daytime alertness and performance in children with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2004;92:344-9.
86. Brozek JL, Bousquet J, Baena-Cagnani CE, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010. J Allergy Clin Immunol. 2010;126:466-7.
87. Potter PC, Van Niekerk CH, Schoeman HS. Effects of triamcinolone on quality of life in patients with persistent allergic rhinitis. Ann Allergy Asthma Immunol. 2003;91:368-74.
88. Mintz M, Garcia J, Diener P, et al. Triamcinolone acetonide aqueous nasal spray improves nocturnal rhinitis-related quality of life in patients treated in a primary care setting: the Quality of Sleep in Allergic Rhinitis study. Ann Allergy Asthma Immunol. 2004;92:255-61.
89. Mansfield LE, Posey CR. Daytime sleepiness and cognitive performance improve in seasonal allergic rhinitis treated with intranasal fluticasone propionate. Allergy Asthma Proc. 2007;28:226-9.
90. Valero A, Izquierdo I, Giralt J, et al. Rupatadine improves nasal symptoms, quality of life (ESPRINT-15) and severity in a subanalysis of a cohort of Spanish allergic rhinitis patients. J Investig Allergol Clin Immunol. 2011;21(3):229-35.
91. Katayose Y, Aritake S, Kitamura S, et al. Carryover effect on next-day sleepiness and psychomotor performance of nighttime administered antihistaminic drugs: a randomized controlled trial. Hum Psychopharmacol Clin Exp. 2012;27:428-36.
92. Milgrom H, Biondi R, Georgitis JW, et al. Comparison of ipratropium bromide 0.03 % with beclomethasone dipropionate in the treatment of perennial rhinitis in children. Ann Allergy Asthma Immunol. 1999;83:105-11.
93. Cingi C, Ozlugedik S. Effects of montelukast on quality of life in patients with persistent allergic rhinitis. Otolaryngol Head Neck Surgery. 2010;142:654-8.
94. Meltzer EO, Malmstrom K, Lu S, et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial. J Allergy Clin Immunol. 2000;105:917-22.
95. Ferguson BJ. Influences of allergic rhinitis on sleep. Otolaryngol Head Neck Surg. 2004;130:617-29.
96. Jáuregui I, Mullol J, Bartra J, et al. H1 antihistamines: psychomotor performance and driving. J Investig Allergol Clin Immunol. 2006;16:S37-44.
97. Montoro J, Mullol J, Dávila I, et al. Bilastine and the central nervous system. J Investig Allergol Clin Immunol. 2011;S3:9-15.
98. Fang BJ, Tonelli LH, Soriano JJ, et al. Disturbed sleep: linking allergic rhinitis, mood and suicidal behavior. Front Biosci. 2010;2:30-46.
99. Smolensky M, di Milia L, Ohayon MM, et al. Sleep disorders, medical conditions, and road accident risk. Accid Anal Prev. 2011;43:533-48.